IDXX FY 2021 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

FY 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$3.2B+18.8% YoY

Gross Profit

$1.9B58.8% margin

Operating Income

$932M29.0% margin

Net Income

$745M23.2% margin

EPS (Diluted)

$8.60

Cash Flow

Operating Cash Flow

$756M

Free Cash Flow

$636M

Stock-Based Comp.

$38M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$1.7B

Stockholders' Equity

$690M

Cash & Equivalents

$144M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.2B	$2.7B	+18.8%
Gross Profit	$1.9B	$1.6B	+20.3%
Operating Income	$932M	$695M	+34.2%
Net Income	$745M	$582M	+28.0%